Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: An immunohistochemical study with CD200 and other stem cell markers

Journal of Cutaneous Pathology

Volumn 42, Issue 2, 2015, Pages 90-101

  Sellheyer, Klaus ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

CD200; cylindroma; spiradenoma; stem cells; sweat gland tumors

Indexed keywords

ANTIGENS, CD200; CYTOKERATIN 15; LEUKOCYTE ANTIGEN; TUMOR MARKER;

ADENOID CYSTIC CARCINOMA; ADOLESCENT; ADULT; AGED; CANCER STEM CELL; FEMALE; HAIR FOLLICLE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SKIN; SWEAT GLAND; SWEAT GLAND TUMOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, ADENOID CYSTIC; ECCRINE GLANDS; FEMALE; HAIR FOLLICLE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-15; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; SKIN; SWEAT GLAND NEOPLASMS; SWEAT GLANDS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84923310680     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12406     Document Type: Article

References (30)

1. Kersting DW, Helwig EB,. Eccrine spiradenoma. AMA Arch Derm 1956; 73: 199.
2. Munger BL, Berghorn BM, Helwig EB,. A light-and electron-microscopic study of a case of multiple eccrine spiradenoma. J Invest Dermatol 1962; 38: 289.
3. Lever WF, Hashimoto K,. Die Histogenese einiger Hautanhangstumoren im Lichte histochemischer und elektronenmikroskopischer Befunde (Ekkrines Porom, ekkrines Spiradenom, Syringom, Cylindrom und unverkalktes Epitheliom). Hautarzt 1966; 17: 161.
4. Hashimoto K, Lever WF,. Histogenesis of skin appendage tumors. Arch Dermatol 1969; 100: 356.
5. Winkelmann RK, Wolff K,. Histochemistry of hidradenoma and eccrine spiradenoma. J Invest Dermatol 1967; 49: 173.
6. McCalmont TH,. Batman and adnexal tumors. J Cutan Pathol 2010; 37: 401.
7. Crain RC, Helwig EB,. Dermal cylindroma (dermal eccrine cylindroma). Am J Clin Pathol 1961; 35: 504.
8. Munger BL, Graham JH, Helwig EB,. Ultrastructure and histochemical characteristics of dermal eccrine cylindroma (turban tumor). J Invest Dermatol 1962; 39: 577.
9. Urbach F, Graham JH, Goldstein J, Munger BL,. Dermal eccrine cylindroma: a histochemical, electron microscopic, and therapeutic (X-ray) study. Arch Dermatol 1963; 88: 880.
10. Cotton DW, Braye SG,. Dermal cylindromas originate from the eccrine sweat gland. Br J Dermatol 1984; 111: 53.
11. Penneys NS, Kaiser M,. Cylindroma expresses immunohistochemical markers linking it to eccrine coil. J Cutan Pathol 1993; 20: 40.
12. Missall TA, Burkemper NM, Jensen SL, Hurley MY,. Immunohistochemical differentiation of four benign eccrine tumors. J Cutan Pathol 2009; 36: 190.
13. Canedo T, de Almeida MP, Cuzzi T, Ramos-e-Silva M,. Immunophenotypic aspects of cylindroma and nodular hidradenoma. J Eur Acad Dermatol Venereol 2010; 24: 178.
14. Sellheyer K,. Stem cell markers can help identify adnexal tumor differentiation when evaluated in the context of morphology: methodology matters. J Cutan Pathol 2011; 38: 460.
15. Kazakov DV, Soukup R, Mukensnabl P, Boudova L, Michal M,. Brooke-Spiegler syndrome: report of a case with combined lesions containing cylindromatous, spiradenomatous, trichoblastomatous, and sebaceous differentiation. Am J Dermatopathol 2005; 27: 27.
16. Chen M, Liu H, Fu X, et al. Brooke-Spiegler syndrome associated with cylindroma, trichoepithelioma and eccrine spiradenoma. Int J Dermatol 2013; 52: 1602.
17. Rasmussen JE,. A syndrome of trichoepitheliomas, milia, and cylindromas. Arch Dermatol 1975; 111: 610.
18. McCalmont TH,. A call for logic in the classification of adnexal neoplasms. Am J Dermatopathol 1996; 18: 103.
19. al-Nafussi A, Blessing K, Rahilly M,. Non-epithelial cellular components in eccrine spiradenoma: a histological and immunohistochemical study of 20 cases. Histopathology 1991; 18: 155.
20. Michal M,. Spiradenoma associated with apocrine adenoma component. Pathol Res Pract 1996; 192: 1135.
21. Meyer KC, Klatte JE, Dinh HV, et al. Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol 2008; 159: 1077.
22. Ohyama M, Terunuma A, Tock CL, et al. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest 2006; 116: 249.
23. Barclay AN, Wright GJ, Brooke G, Brown MH,. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 2002; 23: 285.
24. Sellheyer K, Atanaskova-Mesinkovska N, Nelson P, Bergfeld WF,. Differential expression of stem cell markers in lichen planopilaris and alopecia areata. Br J Dermatol 2011; 165: 1149.
25. Harries MJ, Meyer K, Chaudhry I, et al. Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche. J Pathol 2013; 231: 236.
26. McWhirter JR, Kretz-Rommel A, Saven A, et al. Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. Proc Natl Acad Sci U S A 2006; 103: 1041.
27. Siva A, Xin H, Qin F, Oltean D, Bowdish KS, Kretz-Rommel A,. Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200. Cancer Immunol Immunother 2008; 57: 987.
28. Kazakov DV, Schaller J, Vanecek T, Kacerovska D, Michal M,. Brooke-Spiegler syndrome: report of a case with a novel mutation in the CYLD gene and different types of somatic mutations in benign and malignant tumors. J Cutan Pathol 2010; 37: 886.
29. Misago N, Narisawa Y,. Cytokeratin 15 expression in apocrine mixed tumors of the skin and other benign neoplasms with apocrine differentiation. J Dermatol 2006; 33: 2.
30. Mahalingam M, Srivastava A, Hoang MP,. Expression of stem-cell markers (cytokeratin 15 and nestin) in primary adnexal neoplasms-clues to etiopathogenesis. Am J Dermatopathol 2010; 32: 774.